* AMN Healthcare Services Inc AMN.N AMN is expected
to show a
fall in quarterly revenue when it reports results on February
16.
* The Dallas Texas-based company is expected to report a
21.7% decrease in revenue to $1.067 billion from $1.36 billion a
year ago, according to the mean estimate from 8 analysts, based
on Refinitiv data. The company's guidance on November 3 2022,
for the period ended December 31, was for revenue between 1.05
billion and 1.08 billion.
* Refinitiv's mean analyst estimate for AMN Healthcare
Services
Inc is for earnings of $2.14 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for AMN
Healthcare
Services Inc is $143.5, above its last closing price
of $94.06.
The company's guidance on November 3 2022 for the period ended
December 31 was for Earnings before Interest and Taxes between
112.35 million and 122.04 million.The company's guidance on
November 3 2022 for the period ended December 31 was for
Earnings before Interest, Taxes, Depreciation and Amortization
of between 1.05 billion and 167.4 million.The company's guidance
on November 3 2022 for the period ended December 31 was for
gross profit margin between 33.3% and 33.8%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 2.39 2.37 2.57 Beat 8.5
Jun. 30 2022 2.99 2.97 3.31 Beat 11.6
Mar. 31 2022 3.22 3.20 3.49 Beat 9
Dec. 31 2021 2.77 2.66 2.95 Beat 11.1
Sep. 1.31 1.30 1.73 Beat 32.7
30 2021
Jun. 30 2021 1.43 1.43 1.64 Beat 14.9
Mar. 31 2021 1.37 1.37 1.70 Beat 24.3
Dec. 31 2020 0.90 0.88 1.00 Beat 13.3
This summary was machine generated February 14 at 22:54 GMT.
All figures in US dollars unless otherwise stated